In 2010 I completed my degree in Human Biology at the University of Huddersfield and began my PhD at Aston focusing on medicines research. Here, formulation of oral liquid antihypertensives formed the initial stages of my project; here an understanding of drug action on a molecular level in a physiological setting was essential. In vitro and In vivo characterisation of developed formulations utilising cell and rodent based models paved the way for subsequent genomic investigations into intestinal transporter expression profiling using microarray technology and bioinformatics. Following my PhD I worked as a postdoctoral research fellow at Aston on a project focused on in vitro assessment of taste and was carried out in collaboration with market leading pharmaceutical companies AstraZeneca, GSK, Pfizer and Bristol Myers Squib as well as UCL. During this time I also elevated my teaching profile and arrived at Aston University as a Lecturer in Pharmacy in 2015. Since my lectureship appointment I have been heavily involved with teaching on the MPharm degree programme and I am pursuing my own line of research in formulation design and development. I have recently been awarded funding internally for a PhD studentship investigating the application of 3D printing technology in tablet production which commenced in January 2018. More recent research tracks have seen innovation in the application of nanoparticle formulations to better target administration in hospital settings.
We have known about cases of type 2 diabetes going into remission, or glucose levels going back to normal, since the 1960s. But how likely is it that this treatment will work outside of the carefully controlled environment of a clinical trial?
We have known about cases of type 2 diabetes going into remission, or glucose levels going back to normal, since the 1960s. But how likely is it that this treatment will work outside of the carefully controlled environment of a clinical trial?
Cardiologist; Director of the Heart Failure Unit and Department of Cardiac Rehabilitation, Concord Hospital
We invite you to our first webcast of 2026, where Prof Andrew Sindone will provide an update on heart failure in primary care. Earn up to 4 hours CPD. RACGP & ACRRM accredited.
Clinical Articles
